新生儿胆汁淤积患者胆道闭锁的风险估计:风险评分系统的建立与验证
本研究回顾性纳入2000年1月至2017年2月两家三级转诊医院接受超声和肝胆闪烁显像的新生儿胆汁淤积患者480例,推导队列371例、验证队列109例,以组织病理或术中胆道造影为参考标准,建立并验证了包含足月出生、超声三角形条索征、超声胆囊形态异常及肝胆闪烁显像放射性同位素未排泄至小肠四项变量的7分制评分系统,推导队列C统计量0.981(95%CI 0.970,0.992),验证队列C统计量0.995(95%CI 0.987,1.000)。
要点
- 评分系统含足月出生、超声三角形条索征、超声胆囊形态异常、肝胆闪烁显像未排泄至小肠四项,总分7分。
- 推导队列C统计量0.981(95%CI 0.970,0.992),验证队列0.995(95%CI 0.987,1.000)。
- 推导队列校准P=0.328,验证队列校准P=0.281。
核心结论
- 结合临床与影像特征的简易评分系统有助于准确估计新生儿胆汁淤积患者的胆道闭锁风险。
研究设计与样本
- 回顾性研究,从两家三级转诊医院纳入2000年1月至2017年2月接受超声和肝胆闪烁显像的新生儿胆汁淤积患者480例,推导队列371例、验证队列109例,以组织病理或术中胆道造影为参考标准,采用逻辑回归建立预测模型并转化为评分系统,进行内部和外部验证。
关键影像表现/征象
- 推导队列371例中97例(26.15%)存在胆道闭锁。
- 超声征象包括三角形条索征和胆囊形态异常。
- 肝胆闪烁显像表现为放射性同位素未排泄至小肠。
诊断标准与关键数值
- 评分系统变量为足月出生、超声三角形条索征、超声胆囊形态异常、肝胆闪烁显像放射性同位素未排泄至小肠,最高7分。
- 推导队列C统计量0.981(95%CI 0.970,0.992),验证队列C统计量0.995(95%CI 0.987,1.000)。
- 推导队列校准P=0.328,验证队列校准P=0.281。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To develop and validate a scoring system based on clinical and imaging features to predict the risk for biliary atresia in patients with neonatal cholestasis. Materials and Methods Patients with neonatal cholestasis who underwent both ultrasonography (US) and hepatobiliary scintigraphy (n = 480) were retrospectively identified from two tertiary referral hospitals from January 2000 to February 2017. Patients from one hospital were classified as the derivation cohort (n = 371), and those from the other hospital were classified as the validation cohort (n = 109). Clinical and imaging features associated with biliary atresia were assessed. Histopathologic or intraoperative cholangiographic findings served as the reference standard for biliary atresia. A prediction model was developed by using logistic regression and was then transformed into a scoring system. The scoring system was internally and externally validated. Results Among the 371 patients in the derivation cohort, 97 (26.15%) had biliary atresia. A scoring system was constructed with the following variables: full-term birth, presence of the triangular cord sign at US, abnormal gallbladder morphology at US, and failure of radioisotope excretion to the small bowel at hepatobiliary scintigraphy. The maximum possible score with this system is 7 points. This system enabled differentiation of biliary atresia in the derivation cohort (C statistic, 0.981; 95% confidence interval [CI]: 0.970, 0.992) and the validation cohort (C statistic, 0.995; 95% CI: 0.987, 1.000). The risk score also showed good calibration in both the derivation and the validation cohorts (P = .328 and P = .281, respectively). Conclusion A simple scoring system combining clinical and imaging features can help accurately estimate the risk for biliary atresia in patients with neonatal cholestasis.
引用
- Kim JR, Hwang JY, Yoon HM, et al. Risk Estimation for Biliary Atresia in Patients with Neonatal Cholestasis: Development and Validation of a Risk Score. Radiology. 2018. PMID: 29634437. doi:10.1148/radiol.2018172390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。